SanBio Co Ltd

(SNBIF)

By |

Profile

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

Contact Information

Website: www.sanbio.jp
Main Phone: +81 362643481
Address: 8-1 Street Luke Tower 28th Floor
Address 2: Akashi-cho, Chuo-ku
City / Town: Tokyo
Country: JPN
Postal Code: 104-0044

Issuer Information

Exchange: GREY
Employees: 32


Gathering Data... Please wait

Profile

SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

Contact Information

Website: www.sanbio.jp
Main Phone: +81 362643481
Address: 8-1 Street Luke Tower 28th Floor
Address 2: Akashi-cho, Chuo-ku
City / Town: Tokyo
Country: JPN
Postal Code: 104-0044

Issuer Information

Exchange: GREY
Employees: 32
$ 93.75 $ 0. (0.00%)
Last Price 93.75 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 93.75
Last Trade Volume 0 52 Wk Hi 93.50 52 Wk Low 24.00
Market Cap 4.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,718,705.00 EPS (TTM) -0.47 PE Ratio N/A Exchange Greys